ResearchMoz

Eurocine Vaccines AB - Product Pipeline Review - 2012

Global Markets Direct
Published Date » 2012-09-25
No. Of Pages » 23

Eurocine Vaccines AB Product Pipeline Review 2012

Global Market Directs pharmaceuticals report, Eurocine Vaccines AB Product Pipeline Review 2012 provides data on the Eurocine Vaccines ABs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. 

This report is built using data and information sourced from Global Markets Directs proprietary databases, Eurocine Vaccines ABs corporate website, SEC filings, investor presentations and featured press releases, both from Eurocine Vaccines AB and industry-specific third party sources, put together by Global Markets Directs team. 

Scope

  • Eurocine Vaccines AB Brief Eurocine Vaccines AB overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Eurocine Vaccines AB human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Eurocine Vaccines AB with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones. 
  • Recent updates of the Eurocine Vaccines ABs pipeline in the last quarter. 
  • Key discontinued and dormant projects. 
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Eurocine Vaccines ABs strategic position with total access to detailed information on its product pipeline. 
  • Assess the growth potential of Eurocine Vaccines AB in its therapy areas of focus. 
  • Identify new drug targets and therapeutic classes in the Eurocine Vaccines ABs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. 
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. 
  • Exploit collaboration and partnership opportunities with Eurocine Vaccines AB. 
  • Avoid Intellectual Property Rights related issues. 
  • Explore the dormant and discontinued projects of Eurocine Vaccines AB and identify potential opportunities in those areas.
Table of Contents

Table of Contents 2

List of Tables 3
List of Figures 3
Eurocine Vaccines AB Snapshot 4
Eurocine Vaccines AB Overview 4
Key Information 4
Key Facts 4
Eurocine Vaccines AB Research and Development Overview 5
Key Therapeutic Areas 5
Eurocine Vaccines AB Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products Monotherapy 8
Eurocine Vaccines AB Pipeline Products Glance 9
Eurocine Vaccines AB Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Eurocine Vaccines AB Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Eurocine Vaccines AB Drug Profiles 11
Immunose FLU 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Nasal Pneumococcal Vaccine 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Eurocine Vaccines AB Pipeline Products by Route of Administration 14
Eurocine Vaccines AB Recent Pipeline Updates 15
Eurocine Vaccines AB Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Eurocine Vaccines AB, Recent Developments 17
Eurocine Vaccines AB- Press Release 17
Jan 04, 2012: Eurocine Vaccines, Bionor Pharma And Oslo University Announce Full Enrollment Of Nasal Immunization Study Of Vacc4x And Endocine 17
Dec 03, 2009: Eurocine Vaccines Clinical Trial Fully Recruited 17
Oct 07, 2009: Eurocine Vaccines Begins Nasal Influenza Vaccine Study In Humans 18
Financial Deals Landscape 19
Eurocine Vaccines AB, Deals Summary 19
Eurocine Vaccines AB, Pharmaceuticals & Healthcare, Deal Details 20
Partnerships 20
Eurocine Vaccines Enters Into Collaboration With HeliCure 20
Equity Offering 21
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million 21

Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables


Eurocine Vaccines AB, Key Information 4
Eurocine Vaccines AB, Key Facts 4
Eurocine Vaccines AB Pipeline by Indication, 2012 6
Eurocine Vaccines AB Pipeline by Stage of Development, 2012 7
Eurocine Vaccines AB Monotherapy Products in Pipeline, 2012 8
Eurocine Vaccines AB Phase I, 2012 9
Eurocine Vaccines AB Pre-Clinical, 2012 10
Eurocine Vaccines AB Pipeline By Route of Administration, 2012 14
Eurocine Vaccines AB Recent Pipeline Updates, 2012 15
Eurocine Vaccines AB, Subsidiaries 16
Eurocine Vaccines AB, Deals Summary 19
Eurocine Vaccines Enters Into Collaboration With HeliCure 20
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million 21

List of Figures


Eurocine Vaccines AB Pipeline by Indication, 2012 6
Eurocine Vaccines AB Pipeline by Stage of Development, 2012 7
Eurocine Vaccines AB Monotherapy Products in Pipeline, 2012 8

Upcoming Reports:

Dietary Fiber Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Dietary fiber is that portion of plant food which comprises of two major components, soluble and insoluble. The soluble components are easily transformed into gases and byproducts while insoluble components are fermented mainly in the large intestine as a prebiotic fiber and are usually transformed in bulking fiber. Bulking fibers are known for absorbing a good amount of water thereby easing defecation. Soluble fibers are transformed into gelatinous viscous material and are digested readily by the bacteria present in the digestive tract. The dietary fibers are responsible for the...
Food and Beverage Metal Cans Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
In the early 1990’s, the metal can manufacturing industry experienced a huge leap in demand for its products due to three major reasons: rising costs of existing materials used in the packaging industry, major improvements in metal can manufacture along with slight cost reductions and the end of the cold war which opened up new and emerging markets in the Asia-Pacific region. Add to this the fact that metal cans could be easily recycled and re-used in an in-expensive manner by simply melting the waste. Metal can manufacturing thus became an industry within an industry and started...
Medical Aesthetics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Medical aesthetics is a branch of medical science that deals with the use of artificial organs and body parts for patients who have lost a body part or are in need of corrective surgery on a body part. The growth of the market is attributed by driving factors such as rising disposable incomes of consumers coupled with the rising trend of body altering and the growing number of customer focused aesthetic organizations.   Economic development in the Asia-Pacific region leading to rapid urbanization will act as an opportunity for the market helping in ensuring future...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Microsoft to Complete Nokia Purchase by April 25
Apr 23, 2014  
The Microsoft-Nokia deal that made headlines when it was announced is finally on its way to being completed. This proves that even the most complex deals do culminate with time. This week, Microsoft announced that it would complete the purchase of a major part of Nokia’s hardware assets by Friday. The much discussed deal-though on the brink of completion-has witnessed some adjustments...
Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...